THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 110 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2019. The put-call ratio across all filers is 2.28 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $218,000 | +7.4% | 12,235 | -10.9% | 0.00% | 0.0% |
| Q3 2020 | $203,000 | -41.7% | 13,731 | -17.1% | 0.00% | 0.0% |
| Q2 2020 | $348,000 | -18.7% | 16,568 | -10.4% | 0.00% | -50.0% |
| Q1 2020 | $428,000 | +4.9% | 18,501 | +17.4% | 0.00% | +100.0% |
| Q4 2019 | $408,000 | +19.0% | 15,763 | -10.6% | 0.00% | 0.0% |
| Q3 2019 | $343,000 | +92.7% | 17,637 | +61.3% | 0.00% | 0.0% |
| Q2 2019 | $178,000 | -35.0% | 10,932 | -9.4% | 0.00% | 0.0% |
| Q1 2019 | $274,000 | +27.4% | 12,064 | +43.4% | 0.00% | 0.0% |
| Q4 2018 | $215,000 | +7.0% | 8,412 | +36.6% | 0.00% | 0.0% |
| Q3 2018 | $201,000 | -2.0% | 6,157 | +19.7% | 0.00% | 0.0% |
| Q2 2017 | $205,000 | – | 5,144 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |